Connor, Clark & Lunn Investment Management (CC&L)’s GoodRx Holdings GDRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$473K	Sell	241,548 -1,156,003	-83%	-$2.71M	﹤0.01%	1323
2025 Q4	$3.79M	Sell	1,397,551 -188,546	-12%	-$619K	0.01%	740
2025 Q3	$6.71M	Sell	1,586,097 -85,424	-5%	-$376K	0.02%	502
2025 Q2	$8.32M	Buy	1,671,521 +236,896	+17%	+$1.03M	0.03%	442
2025 Q1	$6.33M	Buy	1,434,625 +205,789	+17%	+$966K	0.03%	439
2024 Q4	$5.71M	Buy	1,228,836 +342,781	+39%	+$1.88M	0.03%	451
2024 Q3	$6.15M	Sell	886,055 -151,465	-15%	-$1.19M	0.03%	390
2024 Q2	$8.09M	Sell	1,037,520 -73,217	-7%	-$542K	0.03%	316
2024 Q1	$7.89M	Buy	1,110,737 +277,381	+33%	+$1.83M	0.03%	339
2023 Q4	$5.58M	Buy	833,356 +97,154	+13%	+$547K	0.03%	391
2023 Q3	$4.14M	Sell	736,202 -84,179	-10%	-$561K	0.02%	442
2023 Q2	$4.53M	Buy	820,381 +120,376	+17%	+$648K	0.02%	418
2023 Q1	$4.38M	Buy	700,005 +408,405	+140%	+$2.28M	0.02%	395
2022 Q4	$1.36M	Buy	+291,600	New	+$1.44M	0.01%	630